Skip to main content
SpringerLink
Log in

Wie hoch ist das Rezidivrisiko bei invasivem Mammakarzinom?

  • Gynäkoonkologie
  • Literatur kompakt
  • Published:
Im Fokus Onkologie Aims and scope

Über das Langzeitrisiko für lokoregionale Rezidive und Fernmetastasen bei Brustkrebspatientinnen war bisher wenig bekannt. Daten aus dem Krebsregister bringen neue Erkenntnisse.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Holleczek B et al. Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis — results from a registry-based study from Germany. BMC Cancer. 2019;19(1):520

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Judith Neumaier

Authors
  1. Judith Neumaier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Neumaier, J. Wie hoch ist das Rezidivrisiko bei invasivem Mammakarzinom?. Im Fokus Onkologie 22, 46–47 (2019). https://doi.org/10.1007/s15015-019-0736-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-019-0736-8

Search

Navigation